Three SIRT3 shRNA lentiviral vectors were used to knock down SIRT3 in AML cells: all of them showed downregulation of SIRT3 mRNA (Fig 2A, left panel) and SIRT3 protein levels (Fig 2A, right panel) as well as cell viability (Figure S1). Here, SIRT3 is linked to acute myeloid leukemia.